AOD9604 5AD 5mg*10vials

AOD9604 5AD 5mg x 10 Vials

Product Overview

AOD9604 5AD is an upgraded highly efficient lyophilized lipolysis research peptide. Based on the classic AOD9604, it is optimized using a unique 5AD advanced molecular modification technology. As an enhanced iteration of the 2AD version, the structural upgrade of 5AD supports molecular affinity, anti-degradation properties, and fat-targeting specificity further improvement research, thus supporting stronger and more stable lipolysis bioactivity research. This product uses a standardized 5mg medium-high concentration specification, suitable for medium-dose gradient experiments, efficient fat metabolism mechanism research, short-term high-intensity metabolic intervention, and fat remodeling efficacy verification. It serves as a high-quality core research material for preclinical obesity mechanism research, lipid deposition regulation, and adipose tissue browning research.

Core Research Functions

Potently Targeting and Activating Lipid Metabolism and Normal Endocrine Levels Appetite Regulation Mechanisms Related Studies: Supports potently targeting and activating lipid metabolism characteristic research, normal endocrine levels or appetite regulation mechanisms interference related studies.

Adipocyte Catabolism Pathway Effective Activation and Subcutaneous Visceral Refractory Fat Oxidative Decomposition Acceleration: Supports adipocyte catabolism pathway effective activation research, subcutaneous and visceral refractory fat oxidative decomposition significant acceleration studies, and adipocytes continuous proliferation and abnormal lipid accumulation inhibition research.

Stronger Lipolysis Efficacy and More Significant Experimental Phenotypes: Supports stronger lipolysis efficacy and more significant experimental phenotypes research compared to the low-dose version of 2AD, lipid metabolism remodeling effective validation research.

Refractory Obesity and Lipid Metabolism Disorders Correction Research: Supports refractory obesity in-depth research, lipid metabolism disorders correction, adipose browning, and medium-dose therapy efficacy threshold exploration research.

Higher In Vivo Stability and Lower Non-Specific Binding and Highly Stable Specific Reproducible Core Data: Supports upgraded 5AD molecular structure higher in vivo stability and lower non-specific binding research, providing highly stable specific reproducible core data for preclinical lipid metabolism studies.

AOD9604 5AD supports potently targeting and activating lipid metabolism characteristic research, normal endocrine levels or appetite regulation mechanisms interference related studies. In laboratory studies, 5AD supports adipocyte catabolism pathway effective activation research, subcutaneous and visceral refractory fat oxidative decomposition significant acceleration studies, and adipocytes continuous proliferation and abnormal lipid accumulation inhibition research. Compared to the low-dose version of 2AD, 5AD supports stronger lipolysis efficacy and more significant experimental phenotypes research, lipid metabolism remodeling effective validation research. The upgraded 5AD molecular structure supports higher in vivo stability and lower non-specific binding research, providing highly stable specific reproducible core data for preclinical lipid metabolism studies.

Core Product Advantages

Advanced Enhanced 5AD Structure: An upgraded iteration based on 2AD modification technology, featuring an optimized molecular stereostructure, stronger lipid-targeting binding affinity, and excellent anti-attenuation capabilities. Compared to the standard AOD9604 and 2AD versions, this product supports more concentrated efficient lipolysis activity research, effectively enhancing experimental phenotypes significance research.

Standard Enhanced Concentration of 5mg: Optimized for medium- to high-dose formulations, addressing low-dose version insufficient efficacy related issue research. Suitable for medium- to high-dose gradient screening and high-efficiency metabolic intervention experiments, balancing experimental safety and phenotypic significance research.

Purely Targeted Lipolysis Mechanism: Supports independent lipid metabolism pathway research, hunger hormones and basal appetite interference related studies, achieving adipocyte metabolism pure regulation research, suitable for lipolysis and lipid improvement mechanisms differentiated research.

High-Purity Lyophilization Process: Utilizes aseptic vacuum lyophilization technology to support peptide activity stable retention research. Each batch undergoes rigorous HPLC purity testing and is accompanied by a complete Certificate of Analysis COA, supporting extremely low impurity content and stable batch consistency research.

Standardized 10-Vial Bulk Packaging: 10 vials per box, using integrated aseptic packaging, meeting the needs of long-term laboratory storage, university lipid metabolism research projects, preclinical drug development, and large-scale wholesale procurement.

Specifications and Quality Control

Format: Lyophilized powder, 5mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis COA.